|
1
|
Metzger-Filho O, de Azambuja E, Bradbury
I, Saini KS, Bines J, Simon SD, Dooren VV, Aktan G, Pritchard KI,
Wolff AC, et al: Analysis of regional timelines to set up a global
phase III clinical trial in breast cancer: The adjuvant lapatinib
and/or trastuzumab treatment optimization experience. Oncologist.
18:134–140. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bower JE, Greendale G, Crosswell AD, Garet
D, Sternlieb B, Ganz PA, Irwin MR, Olmstead R, Arevalo J and Cole
SW: Yoga reduces inflammatory signaling in fatigued breast cancer
survivors: A randomized controlled trial. Psychoneuroendocrinology.
43:20–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pu Z, Zhang X, Chen Q, Yuan X and Xie H:
Establishment of an expression platform of OATP1B1 388GG and 521CC
genetic polymorphism and the therapeutic effect of tamoxifen in
MCF-7 cells. Oncol Rep. 33:2420–2428. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rodin D, Knaul FM, Lui TY and
Gospodarowicz M: Radiotherapy for breast cancer: The predictable
consequences of an unmet need. Breast. 29:120–122. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fisher B, Anderson S, Bryant J, Margolese
RG, Deutsch M, Fisher ER, Jeong JH and Wolmark N: Twenty-year
follow-up of a randomized trial comparing total mastectomy,
lumpectomy, and lumpectomy plus irradiation for the treatment of
invasive breast cancer. N Engl J Med. 347:1233–1241. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim JJ and Tannock IF: Repopulation of
cancer cells during therapy: An important cause of treatment
failure. Nat Rev Cancer. 5:516–525. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Peitzsch C, Kurth I, Kunz-Schughart L,
Baumann M and Dubrovska A: Discovery of the cancer stem cell
related determinants of radioresistance. Radiother Oncol.
108:378–387. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gerber DE: Targeted therapies: A new
generation of cancer treatments. Am Fam Physician. 77:311–319.
2008.PubMed/NCBI
|
|
9
|
Haraguchi H, Kataoka S, Okamoto S, Hanafi
M and Shibata K: Antimicrobial triterpenes from Ilex integra and
the mechanism of antifungal action. Phytother Res. 13:151–156.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao WM, Wolfender JL, Hostettmann K,
Cheng KF, Xu RS and Qin GW: Triterpenes and triterpenoid saponins
from Mussaenda pubescens. Phytochemistry. 45:1073–1078. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bhattacharyya J and de Almeida MZ:
Isolation of the constituents of the root-bark of Guettarda
platypoda. J Nat Prod. 48:148–149. 1985. View Article : Google Scholar
|
|
12
|
Saimaru H, Orihara Y, Tansakul P, Kang YH,
Shibuya M and Ebizuka Y: Production of triterpene acids by cell
suspension cultures of Olea europaea. Chem Pharm Bull (Tokyo).
55:784–788. 2007. View Article : Google Scholar
|
|
13
|
Lee TH, Juang SH, Hsu FL and Wu CY:
Triterpene acids from the leaves of Planchonella duclitan (Blanco)
Bakhuizan. J Chin Chem Soc (Taipei). 52:1275–1280. 2005. View Article : Google Scholar
|
|
14
|
Kim MH, Park KH, Oh MH, Kim HH, Choe KI,
Park SH and Lee MW: Two new hemiterpene glycosides from the leaves
of Ilex otunda. Thunb Arch Pharm Res. 35:1779–84. 2012. View Article : Google Scholar
|
|
15
|
Lin FP, Shao JW, Du HD, Dai YC and Wang T:
Synthesis, characterization and anti-tumor activity of ursolic acid
derivatives. Chin J Appl Chem. 27:893–898. 2010.Chinese.
|
|
16
|
Darby S, McGale P, Correa C, Taylor C,
Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, et
al Early Breast Cancer Trialists’ Collaborative Group (EBCTCG):
Effect of radiotherapy after breast-conserving surgery on 10-year
recurrence and 15-year breast cancer death: Meta-analysis of
individual patient data for 10,801 women in 17 randomised trials.
Lancet. 378:1707–1716. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Darby SC, Ewertz M, McGale P, Bennet AM,
Blom-Goldman U, Brønnum D, Correa C, Cutter D, Gagliardi G, Gigante
B, et al: Risk of ischemic heart disease in women after
radiotherapy for breast cancer. N Engl J Med. 368:987–998. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hayes SB, Freedman GM, Li T, Anderson PR
and Ross E: Does axillary boost increase lymphedema compared with
supraclavicular radiation alone after breast conservation? Int J
Radiat Oncol Biol Phys. 72:1449–1455. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sandoo A, Kitas GD and Carmichael AR:
Breast cancer therapy and cardiovascular risk: Focus on
trastuzumab. Vasc Health Risk Manag. 11:223–228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lian L, Li W, Li ZY, Mao YX, Zhang YT,
Zhao YM, Chen K, Duan WM and Tao M: Inhibition of MCF-7 breast
cancer cell-induced platelet aggregation using a combination of
antiplatelet drugs. Oncol Lett. 5:675–680. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li W, Liang RR, Zhou C, Wu MY, Lian L,
Yuan GF, Wang MY, Xie X, Shou LM, Gong FR, et al: The association
between expressions of Ras and CD68 in the angiogenesis of breast
cancers. Cancer Cell Int. 15:172015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shou LM, Zhang QY, Li W, Xie X, Chen K,
Lian L, Li ZY, Gong FR, Dai KS, Mao YX, et al: Cantharidin and
norcantharidin inhibit the ability of MCF-7 cells to adhere to
platelets via protein kinase C pathway-dependent downregulation of
α2 integrin. Oncol Rep. 30:1059–1066. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Majeed W, Aslam B, Javed I, Khaliq T,
Muhammad F, Ali A and Raza A: Breast cancer: Major risk factors and
recent developments in treatment. Asian Pac J Cancer Prev.
15:3353–3358. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee CL, Blum JM and Kirsch DG: Role of p53
in regulating tissue response to radiation by mechanisms
independent of apoptosis. Transl Cancer Res. 2:412–421. 2013.
|
|
25
|
Menon V and Povirk L: Involvement of p53
in the repair of DNA double strand breaks: Multifaceted roles of
p53 in homologous recombination repair (HRR) and non-homologous end
joining (NHEJ). Subcell Biochem. 85:321–336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu D, Su C, Jiang M, Shen Y, Shi A, Zhao
F, Chen R, Shen Z, Bao J and Tang W: Fenofibrate inhibited
pancreatic cancer cells proliferation via activation of p53
mediated by upregulation of LncRNA MEG3. Biochem Biophys Res
Commun. 471:290–295. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He YF, Nan ML, Sun JM, Meng ZJ, Yue FG,
Zhao QC, Yang XH and Wang H: Synthesis, characterization and
cytotoxicity of new rotundic acid derivatives. Molecules.
17:1278–1291. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
29
|
Kim GD, Choi YH, Dimtchev A, Jeong SJ,
Dritschilo A and Jung M: Sensing of ionizing radiation-induced DNA
damage by ATM through interaction with histone deacetylase. J Biol
Chem. 274:31127–31130. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu XY, Zhang FR, Shang JY, Liu YY, Lv XF,
Yuan JN, Zhang TT, Li K, Lin XC, Liu X, et al: Renal inhibition of
miR-181a ameliorates 5-fluorouracil-induced mesangial cell
apoptosis and nephrotoxicity. Cell Death Dis. 9:6102018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zaki I, Abdelhameid MK, El-Deen IM, Abdel
Wahab AHA, Ashmawy AM and Mohamed KO: Design, synthesis and
screening of 1, 2, 4-triazinone derivatives as potential antitumor
agents with apoptosis inducing activity on MCF-7 breast cancer cell
line. Eur J Med Chem. 156:563–579. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Singh PK, Weber A and Häcker G: The
established and the predicted roles of dynein light chain in the
regulation of mitochondrial apoptosis. Cell Cycle. 18:1–11.
2018.
|
|
33
|
O’Brien KM, Sandler DP, Xu Z, Kinyamu HK,
Taylor JA and Weinberg CR: Vitamin D, DNA methylation, and breast
cancer. Breast Cancer Res. 20:702018. View Article : Google Scholar
|
|
34
|
Mrózek E, Layman R, Ramaswamy B, Lustberg
M, Vecchione A, Knopp MV and Shapiro CL: Phase II trial of
neoadjuvant weekly nanoparticle albumin-bound paclitaxel,
carboplatin, and biweekly bevacizumab therapy in women with
clinical stage II or III HER2-negative breast cancer. Clin Breast
Cancer. 14:228–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zuo S, Liu C, Wang J, Wang F, Xu W, Cui S,
Yuan L, Chen X, Fan W, Cui M, et al: IGFBP-rP1 induces p21
expression through a p53-independent pathway, leading to cellular
senescence of MCF-7 breast cancer cells. J Cancer Res Clin Oncol.
138:1045–1055. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shokouh TZ, Ezatollah A and Barand P:
Interrelationships Between Ki67, HER2/neu, p53, ER, and PR status
and their associations with tumor grade and lymph node involvement
in breast carcinoma subtypes: Retrospective-observational
analytical study. Medicine (Baltimore). 94:e13592015. View Article : Google Scholar
|
|
37
|
Zhao QC, Nan ML, He YF and Chen SW:
Application of rotundic Aacid in the cardiovascular disease
prevention. CHN Patent 201010204596.9. 2010, Chinese.
|
|
38
|
Zhao QC, Nan ML, He YF and Chen SW:
Application of rotundic acid in the preparation of lipid-lowering
drugs. CHN. 201010204607:32010.Chinese.
|
|
39
|
Cao W, Gu Y, Meineck M and Xu H: The
combination of chemotherapy and radiotherapy towards more efficient
drug delivery. Chem Asian J. 9:48–57. 2014. View Article : Google Scholar
|
|
40
|
Li SJ, Liang XY, Li HJ, Yang GZ, Li W, Li
Z, Zhou L, Wen X, Yu DH and Cui JW: Low-dose irradiation inhibits
proliferation of the p53null type human prostate cancer cells
through the ATM/p21 pathway. Int J Mol Med. 41:548–554. 2018.
|
|
41
|
Suzuki K, Okada H, Yamauchi M, Oka Y,
Kodama S and Watanabe M: Qualitative and quantitative analysis of
phosphorylated ATM foci induced by low-dose ionizing radiation.
Radiat Res. 165:499–504. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Viniegra JG, Martínez N, Modirassari P,
Hernández Losa J, Parada Cobo C, Sánchez-Arévalo Lobo VJ, Aceves
Luquero CI, Alvarez-Vallina L, Ramón y Cajal S, Rojas JM, et al:
Full activation of PKB/Akt in response to insulin or ionizing
radiation is mediated through ATM. J Biol Chem. 280:4029–4036.
2005. View Article : Google Scholar
|
|
43
|
Yin J, Wang F, Kong Y, Wu R, Zhang G, Wang
N, Wang L, Lu Z and Liang M: Antithrombin III prevents progression
of chronic kidney disease following experimental
ischaemic-reperfusion injury. J Cell Mol Med. 21:3506–3514. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lu Z, Cheng D, Yin J, Wu R, Zhang G, Zhao
Q, Wang N, Wang F and Liang M: Antithrombin III protects against
contrast-induced nephropathy. EBioMedicine. 17:101–107. 2017.
View Article : Google Scholar : PubMed/NCBI
|
